These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [General principles of cancer chemotherapy]. Orzechowska-Juzwenko K Pol Tyg Lek; 1983 Dec 19-26; 38(51-52):1675-8. PubMed ID: 6679091 [No Abstract] [Full Text] [Related]
6. Sensitivity of latent cancer to chemotherapy. Schrek R Med Hypotheses; 1992 Jul; 38(3):215-6. PubMed ID: 1513276 [TBL] [Abstract][Full Text] [Related]
7. [Criteria for the determination of the efficacy of solid cancer chemotherapy]. Saito T Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):626-34. PubMed ID: 3954385 [No Abstract] [Full Text] [Related]
8. Clinical and scientific considerations in preoperative (neoadjuvant) chemotherapy. Frei E; Miller D; Clark JR; Fallon BG; Ervin TJ Recent Results Cancer Res; 1986; 103():1-5. PubMed ID: 3738192 [No Abstract] [Full Text] [Related]
9. Implications of certain cell kinetic and biological parameters for preoperative chemotherapy. Hill BT Recent Results Cancer Res; 1986; 103():41-53. PubMed ID: 3526475 [No Abstract] [Full Text] [Related]
10. The cancer stem cell gamble. Kaiser J Science; 2015 Jan; 347(6219):226-9. PubMed ID: 25593170 [No Abstract] [Full Text] [Related]
11. Thinking Systematically About the Off-Label Use of Cancer Drugs and Combinations for Patients Who Have Exhausted Proven Therapies. Mailankody S; Prasad V Oncologist; 2016 Sep; 21(9):1031-2. PubMed ID: 27401893 [TBL] [Abstract][Full Text] [Related]
12. Chemotherapy for metastatic disease. Carter SK Symp Fundam Cancer Res; 1983; 36():397-410. PubMed ID: 6382516 [No Abstract] [Full Text] [Related]